Ratio Speciality Company for Trading (TADAWUL:9630)
Saudi Arabia · Delayed Price · Currency is SAR 9.25
+0.15 (1.65%)
Jul 31, 2025, 12:20 PM AST
Checkpoint Therapeutics Revenue
In the year 2024, Ratio Speciality Company for Trading had annual revenue of 46.89M SAR with 8.15% growth. Ratio Speciality Company for Trading had revenue of 12.07M in the quarter ending December 31, 2024.
Revenue
46.89M
Revenue Growth
+8.15%
P/S Ratio
3.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
185.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.89M | 3.53M | 8.15% |
| Dec 31, 2023 | 43.36M | 7.47M | 20.82% |
| Dec 31, 2022 | 35.89M | 10.40M | 40.81% |
| Dec 31, 2021 | 25.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition